We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$6.75B
AUM Growth
+$963M
Cap. Flow
+$702M
Cap. Flow %
10.4%
Top 10 Hldgs %
4.5%
Holding
2,736
New
363
Increased
1,147
Reduced
950
Closed
272

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$38.5M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31M
3
LIN icon
Linde
LIN
+$30.2M
4
NKE icon
Nike
NKE
+$27.1M
5
EOG icon
EOG Resources
EOG
+$26.9M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$35.3M
2
HD icon
Home Depot
HD
+$29.9M
3
SCHW
Charles Schwab
SCHW
+$26.7M
4
FISV
Fiserv Inc
FISV
+$26M
5
LMT icon
Lockheed Martin
LMT
+$25.9M

Sector Composition

Rank Sector Weight
1 Technology 15.69%
2 Consumer Discretionary 15.21%
3 Industrials 13.29%
4 Financials 13.23%
5 Healthcare 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIG
2451
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$4K ﹤0.01%
+234
New +$3.57K
MNK
2452
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4K ﹤0.01%
3,933
-4,020
-51% -$7.12K
GTE icon
2453
Gran Tierra Energy
GTE
$317M
$3K ﹤0.01%
1,250
– –
LPRO
2454
DELISTED
Open Lending Corp
LPRO
$3K ﹤0.01%
+100
New +$1.95K
PRLD icon
2455
Prelude Therapeutics
PRLD
$390M
$3K ﹤0.01%
+100
New +$2.82K
AZRE
2456
DELISTED
Azure Power Global Limited
AZRE
$3K ﹤0.01%
+108
New +$2.48K
OTIC
2457
DELISTED
Otonomy, Inc.
OTIC
$3K ﹤0.01%
+864
New +$3.26K
PRVL
2458
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$3K ﹤0.01%
+300
New +$4.03K
ERF
2459
DELISTED
Enerplus Corporation
ERF
$1K ﹤0.01%
390
-59,792
-99% -$149K
GTH
2460
DELISTED
Genetron Holdings Limited ADS
GTH
$1K ﹤0.01%
+30
New +$1.15K
KDNY
2461
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
+112
New +$1.5K
ABCB icon
2462
Ameris Bancorp
ABCB
$5.89B
– –
-80,874
Closed -$1.91M
ABEO icon
2463
Abeona Therapeutics
ABEO
$413M
– –
-336
Closed -$25K
ABUS icon
2464
Arbutus Biopharma
ABUS
$915M
– –
-12,562
Closed -$23K
ACMR icon
2465
ACM Research
ACMR
$5.79B
– –
-96,357
Closed -$2M
ACRE
2466
Ares Commercial Real Estate
ACRE
$270M
– –
-36,381
Closed -$332K
ADAP
2467
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-19,744
Closed -$198K
ADM icon
2468
Archer Daniels Midland
ADM
$36.9B
– –
-16,340
Closed -$652K
AEG icon
2469
Aegon
AEG
$14.1B
– –
-36,974
Closed -$100K
AGYS icon
2470
Agilysys
AGYS
$3.06B
– –
-19,022
Closed -$341K
AIV
2471
Aimco
AIV
$383M
– –
-363,502
Closed -$1.82M
AIZ icon
2472
Assurant
AIZ
$14.3B
– –
-18,986
Closed -$1.96M
ALLO icon
2473
Allogene Therapeutics
ALLO
$694M
– –
-11,943
Closed -$511K
AMPH icon
2474
Amphastar Pharmaceuticals
AMPH
$916M
– –
-41,009
Closed -$921K
ANIK icon
2475
Anika Therapeutics
ANIK
$287M
– –
-7,783
Closed -$294K
97 98
99
100 101

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q3 2020 Portfolio in Review

As of Q3 2020, Cubist Systematic Strategies held 2,736 positions worth $6.75B, up 17% from $5.79B the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Cubist Systematic Strategies deployed $702M of net new capital in Q3 2020, opening 363 new positions and adding to 1,147 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 93,678 shares worth $31.4M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Capital One, an estimated $35.3M trimmed.

  • Cubist Systematic Strategies's largest Q3 2020 buy was State Street SPDR S&P 500 ETF Trust: 93,678 shares worth $31.4M.
  • Cubist Systematic Strategies added most to Visa in Q3 2020, an estimated $38.5M increase.
  • Cubist Systematic Strategies's biggest Q3 2020 reduction was Capital One, cutting an estimated $35.3M.
  • Cubist Systematic Strategies fully exited Steris in Q3 2020, selling an estimated $19.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.5% of its $6.75B portfolio in Q3 2020.
  • Cubist Systematic Strategies opened 363 new positions and closed 272 in Q3 2020.
  • Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $6.75B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.